The American Academy of Ophthalmology stated that is commends the US House of Representatives for surpassing the 290-cosponsor milestone in support of H.R. 3173, the "Improving Seniors’ Timely Access to Care Act of 2021."

Spark Therapeutics, a part of the Roche Group, announced that Ron Philip, the company's COO, will take over as CEO from co-founder Jeffrey D. Marrazzo. Mr. Marrazzo, who joined the company as a co-founder in 2013, will step down on April 1.

Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.

Omeros has completed the sale of Omidria (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group.

AffaMed Therapeutics and Hanmi Pharmaceutical Co. have entered into a licensing agreement, according to a company news release.

Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,.

Retina Consultants of America (RCA) has added Associated Vitreoretinal and Uveitis Consultants (AVRUC) to its national consortium.

The US Department of Defense (DoD) has awarded Weill Cornell Medicine a $1.27 million grant to develop a treatment for a rare but deadly eye disease that mostly affects military members who have suffered traumatic eye injuries in combat.

Oculentis B.V. has been declared bankrupt by order of the District Court Gelderland of September 6, 2021. Mr. E.R. Looijen is the bankruptcy trustee, and Mr. M.J.C. van Leeuwen is the delegated judge.

Schwind eye-tech-solutions has received funding for a new research project aimed at developing an ophthalmic laser system with ultra-short laser pulses[1], according to a company announcement.